Search research articles
Contact Us
Filters
Showing results (361-370 of 394) with videos related to
Page
of 40
Sort By:
American Journal of Therapeutics
|
May 21, 2009
Low-dose spironolactone: effects on artery-to-artery vein grafts and percutaneous coronary intervention sites
Matthew D Bacchetta, Arash Salemi, Federico Milla, et al.
Journal of the American College of Cardiology
|
March 24, 2018
Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes
Bhupendar Tayal, John Gorcsan, Jeroen J Bax, et al.
Journal of the American College of Cardiology
|
April 21, 2018
Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen
Grant W Reed, Mouin S Abdallah, Mingyuan Shao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 22, 2017
Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical Trial
Daniel H Solomon, M Elaine Husni, Katherine E Wolski, et al.
European Journal of Heart Failure
|
November 19, 2016
Effect of cardiac resynchronization therapy in patients with diabetes randomized in EchoCRT
Matthias P Nägele, Jan Steffel, Michele Robertson, et al.
Alimentary Pharmacology & Therapeutics
|
April 19, 2018
Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial
N D Yeomans, D Y Graham, M E Husni, et al.
European Heart Journal
|
February 6, 2013
Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy
Freek W A Verheugt, Peter Clemmensen, Roxana Mehran, et al.
American Heart Journal
|
April 1, 2009
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis
Matthew C Becker, Thomas H Wang, Lisa Wisniewski, et al.
Heart (British Cardiac Society)
|
April 30, 2017
Streamlining cardiovascular clinical trials to improve efficiency and generalisability
Faiez Zannad, Marc A Pfeffer, Deepak L Bhatt, et al.
European Journal of Heart Failure
|
August 10, 2013
Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties
Daniela Dobre, Jeffrey S Borer, Kim Fox, et al.
Page
of 40
Search research articles
Search
Showing results (361-370 of 394) with videos related to
Sort By:
Page
of 40
American Journal of Therapeutics
|
May 21, 2009
Low-dose spironolactone: effects on artery-to-artery vein grafts and percutaneous coronary intervention sites
Matthew D Bacchetta, Arash Salemi, Federico Milla, et al.
Journal of the American College of Cardiology
|
March 24, 2018
Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes
Bhupendar Tayal, John Gorcsan, Jeroen J Bax, et al.
Journal of the American College of Cardiology
|
April 21, 2018
Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen
Grant W Reed, Mouin S Abdallah, Mingyuan Shao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 22, 2017
Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical Trial
Daniel H Solomon, M Elaine Husni, Katherine E Wolski, et al.
European Journal of Heart Failure
|
November 19, 2016
Effect of cardiac resynchronization therapy in patients with diabetes randomized in EchoCRT
Matthias P Nägele, Jan Steffel, Michele Robertson, et al.
Alimentary Pharmacology & Therapeutics
|
April 19, 2018
Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial
N D Yeomans, D Y Graham, M E Husni, et al.
European Heart Journal
|
February 6, 2013
Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy
Freek W A Verheugt, Peter Clemmensen, Roxana Mehran, et al.
American Heart Journal
|
April 1, 2009
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis
Matthew C Becker, Thomas H Wang, Lisa Wisniewski, et al.
Heart (British Cardiac Society)
|
April 30, 2017
Streamlining cardiovascular clinical trials to improve efficiency and generalisability
Faiez Zannad, Marc A Pfeffer, Deepak L Bhatt, et al.
European Journal of Heart Failure
|
August 10, 2013
Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties
Daniela Dobre, Jeffrey S Borer, Kim Fox, et al.
Page
of 40